• COVID-19 in the EU: Inpatient Treatment of Mild to Moderate COVID-19 in Patients Who Are Immunocompromised

  • Feb 6 2025
  • Length: 13 mins
  • Podcast

COVID-19 in the EU: Inpatient Treatment of Mild to Moderate COVID-19 in Patients Who Are Immunocompromised

Listen for free

View show details

  • Summary

  • In this episode, Martin Witzenrath, MD, FERS, and Michele Bartoletti, MD, PhD, discuss the management of mild to moderate COVID-19 in patients who are immunocompromised, including:

    • Initial workup, which may include laboratory tests and/or imaging
    • Latest data on the use of remdesivir or nirmatrelvir plus ritonavir for mild to moderate COVID-19, including considerations for drug–drug interactions

    Presenters:

    Martin Witzenrath, MD, FERS
    Medical Director
    Charite Centrum 12
    Internal Medicine & Dermatology
    Professor and Chair for Respiratory Medicine and Critical Care
    Department of Infectious Disease, Respiratory Medicine and Critical Care
    Charite Campus Mitte/Campus Virchow Klinikum/Campus Benjamin Franklin
    Charite – University of Berlin
    Berlin, Germany

    Michele Bartoletti, MD, PhD
    Associate Professor of Infectious Diseases
    Department of Biomedical Sciences
    Humanitas University
    Pieve Emanuele (MI), Italy
    Head of Infectious Diseases Unit
    IRCCS Humanitas Research Hospital
    Rozzano (MI), Italy

    Link to full program:
    https://bit.ly/4gu2gcU

    Downloadable slides:
    https://bit.ly/3CGlDBS

    Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
    Show more Show less
Show more Show less
adbl_web_global_use_to_activate_webcro768_stickypopup

What listeners say about COVID-19 in the EU: Inpatient Treatment of Mild to Moderate COVID-19 in Patients Who Are Immunocompromised

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available